Leadership2020-11-04T07:25:55+00:00

Leadership

Ammad Khan

Co-Founder and CEO

Ammad’s experience spans a variety of companies at the intersection of medicine and technology, where he has led the company’s mission to enable millions of legally blind people to, “see clearly and live fully.” Under his guidance, IrisVision has secured funding from the National Eye Institute and other prestigious investors, forged partnerships with global industry leaders such as Samsung and expanded global sales across North America, Europe and Australia. A thought leader in medtech, vision assistive and mobile technologies, Ammad has spoken at many technology and vision science events and has been quoted in Forbes, Fast Company and the New York Times.

Prior to IrisVision, Ammad founded and served as CEO of CitrusBits, a mobile app agency that creates award-winning mobile technology and applications for global brands such as Mercedes-Benz, Burger King, Quiksilver, Symantec, and Sotheby’s.

Dr. Frank Werblin

Co-Founder, Chief Scientist

IrisVision was founded by Dr. Frank Werblin, an MIT graduate, Guggenheim Fellow, and professor at UC Berkeley. Dr. Werblin is renowned for his scientific contributions to our understanding of retinal functioning. He has dedicated his life to innovating, developing and delivering an affordable non-invasive solution for millions of people with low vision.

With the help of our research partners at Stanford, Johns Hopkins, UC Berkeley, UPMC, The Chicago Lighthouse for the Blind, and other institutions contributing to low vision science, IrisVision is the realization of that lifetime of work. He is dedicated to pushing the boundaries of low vision solutions by continuing to expand the relationship with top vision scientists and technology powerhouses like Samsung.

Leadership

DINO DE CICCO

Vice President, Product and Strategy

Dino brings more than two decades of experience in R&D, product innovation and strategic planning in the medical device field. Over the course of his career, De Cicco has served in senior product roles for such companies as Medtronic, Bacchus Vascular, PHILIPS, and Nexgen…

READ MORE

TOM PERSKI

Vice President, Professional and Consumer Outreach

With a career spanning 35 years, Tom is a pioneer in the field of low-vision. He founded Macular Degeneration International where he published low-vision journals, and Southwest Low Vision providing service and technology for the low vision community…

READ MORE

ALLISON SOJKA

Vice President, Marketing

Allison has a 25-year marketing career characterized by leadership at game-changing companies which have re-set the standard in their categories in the medical device field, helping build some of the most notable brands in the rehabilitation industry. Her entre to healthcare marketing began with…

READ MORE

KIP THENO

Vice President, Sales and Strategic Partnerships

Kip brings more than twenty years of experience in executive sales management and leadership for an array of medtech companies. Kip was the founding Vice President of U.S. Sales for iCardio Corporation commercializing the advanced cardiovascular…

READ MORE

Advisors

BROOK BYERS

Advisor

Brook Byers is a distinguished entrepreneur and a founder of the venture capital company KPCB (Kleiner Perkins Caufield & Byers). Byers has been closely involved with more than fifty new technology-based ventures, over half of which have already become public companies…

READ MORE

TIM DRISCOLL

Advisor

Tim Driscoll is an accomplished CFO for venture-backed companies who has the ability to build and support high performing organizations during periods of rapid scaling. He has 16 years of successful experience in executive and consultant/advisory roles with technology…

READ MORE

MATT JOHNSON

Advisor

Matt Johnson is a globally recognized expert in the field of brand marketing. Having worked with over 200 companies in over 30 countries, he has profound experience leading corporate pricing transformations, optimization, and software implementation across a broad range of…

READ MORE

NAEEM KAYANI

Advisor

Naeem Kayani is a skilled marketing and product manager with vast experience in the field of software technology. He has contributed to the digital transformation of companies such as Nationstar Mortgage to Mr. Cooper, and has led numerous start-ups through exponential…

READ MORE

Scientific Advisory Board

DR. MARK BLUMENKRANZ

Advisor

Surgeon and Entrepreneur, Professor & Former chair of Ophthalmology, Stanford University

Dr. Blumenkranz, M.D., MMS, is HJ Smead Professor Emeritus in the Department of Ophthalmology at Stanford University. He is a past President of the American University Professors of Ophthalmology (AUPO), a past President of the Retina Society and the Macula…

READ MORE

Dr. Paul B. Freeman

Advisor

Head of Low Vision Rehabilitation Services, Allegheny General Hospital

Dr. Paul B. Freeman is an optometrist and the head of low vision rehabilitation services at Allegheny General Hospital in Pittsburgh, Pennsylvania and provides low vision rehabilitation services throughout multiple clinics in Pennsylvania. He lectures both nationally and internationally…

READ MORE

DR. JEFFREY GOLDBERG

Advisor

Professor and Chair of Ophthalmology, Byers Eye Institute at Stanford University

Dr. Jeffrey Goldberg is Professor and Chair of Ophthalmology at the Byers Eye Institute at Stanford University. His clinical effort is focused on patients in need of medical or surgical intervention for glaucoma and other retinal and optic nerve diseases, as well as cataract. He was elected in 2010…

READ MORE

DR. ROGER GOLDBERG

Advisor

Ophthalmologist

Dr. Goldberg is board certified by the American Board of Ophthalmology, and is an active member of the American Society of Retinal Specialists and the American Academy of Ophthalmology. He serves as a Reviewer for the AJO and Retina, and has lectured at national and international…

READ MORE

DR. ERICH HORN

Advisor & Investor

Ophthalmologist, University of Florida

Dr. Horn, M.D., MBA, is a board-certified ophthalmologist. He serves as an associate professor in the department of ophthalmology at the University of Florida College of Medicine. He is a member of the American Academy of Ophthalmology, Florida Medical…

READ MORE

DR. BOB MASSOF

Advisor

Professor of Ophthalmology, Johns Hopkins School of Medicine

Dr. Massof, Ph.D., is a professor of ophthalmology and professor of neuroscience at the Johns Hopkins University School of Medicine. He is founder and director of the Lions Vision Research and Rehabilitation Center at the Wilmer Eye Institute. He also entered a…

READ MORE

DR. DAVID MYUNG

Advisor

Assistant Professor of Ophthalmology Stanford University, Physician and Surgeon — VA Health Care System

Dr. Myung is an Assistant Professor of Ophthalmology at the Byers Eye Institute at Stanford and, by courtesy, of Chemical Engineering. He is a board-certified ophthalmologist and attending physician at the VA Palo Alto Health Care System specializing in cataract…

READ MORE

DR. FRANK ZHENG

Advisor

Optometrist

Dr. Zheng graduated from the UC Berkeley School of Optometry and received his Doctor of Optometry. He then focused his post-graduate training at Pacific University in the Cornea and Contact Lens Residency program and obtained his Masters in Contact Lens and Myopia Control…

READ MORE

Ammad Khan

CEO

Ammad Khan

Ammad’s experience spans a variety of companies at the intersection of medicine and technology, where he has led the company’s mission to enable millions of legally blind people to, “see clearly and live fully.” Under his guidance, IrisVision has secured funding from the National Eye Institute and other prestigious investors, forged partnerships with global industry leaders such as Samsung and expanded global sales across North America, Europe and Australia. A thought leader in medtech, vision assistive and mobile technologies, Ammad has spoken at many technology and vision science events and has been quoted in Forbes, Fast Company and the New York Times.

Ammad Khan

CEO

Ammad Khan

Ammad’s experience spans a variety of companies at the intersection of medicine and technology, where he has led the company’s mission to enable millions of legally blind people to, “see clearly and live fully.” Under his guidance, IrisVision has secured funding from the National Eye Institute and other prestigious investors, forged partnerships with global industry leaders such as Samsung and expanded global sales across North America, Europe and Australia. A thought leader in medtech, vision assistive and mobile technologies, Ammad has spoken at many technology and vision science events and has been quoted in Forbes, Fast Company and the New York Times.

Ammad Khan

CEO

Ammad Khan

Ammad’s experience spans a variety of companies at the intersection of medicine and technology, where he has led the company’s mission to enable millions of legally blind people to, “see clearly and live fully.” Under his guidance, IrisVision has secured funding from the National Eye Institute and other prestigious investors, forged partnerships with global industry leaders such as Samsung and expanded global sales across North America, Europe and Australia. A thought leader in medtech, vision assistive and mobile technologies, Ammad has spoken at many technology and vision science events and has been quoted in Forbes, Fast Company and the New York Times.

Ammad’s experience spans a variety of companies at the intersection of medicine and technology, where he has led the company’s mission to enable millions of legally blind people to, “see clearly and live fully.” Under his guidance, IrisVision has secured funding from the National Eye Institute and other prestigious investors, forged partnerships with global industry leaders such as Samsung and expanded global sales across North America, Europe and Australia. A thought leader in medtech, vision assistive and mobile technologies, Ammad has spoken at many technology and vision science events and has been quoted in Forbes, Fast Company and the New York Times.

Ammad’s experience spans a variety of companies at the intersection of medicine and technology, where he has led the company’s mission to enable millions of legally blind people to, “see clearly and live fully.” Under his guidance, IrisVision has secured funding from the National Eye Institute and other prestigious investors, forged partnerships with global industry leaders such as Samsung and expanded global sales across North America, Europe and Australia. A thought leader in medtech, vision assistive and mobile technologies, Ammad has spoken at many technology and vision science events and has been quoted in Forbes, Fast Company and the New York Times.

Ammad’s experience spans a variety of companies at the intersection of medicine and technology, where he has led the company’s mission to enable millions of legally blind people to, “see clearly and live fully.” Under his guidance, IrisVision has secured funding from the National Eye Institute and other prestigious investors, forged partnerships with global industry leaders such as Samsung and expanded global sales across North America, Europe and Australia. A thought leader in medtech, vision assistive and mobile technologies, Ammad has spoken at many technology and vision science events and has been quoted in Forbes, Fast Company and the New York Times.